Drug Trial Radar · NCT06436183
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Sep 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
62
Actual
Start
May 1, 2024
Primary completion
Mar 26, 2025
Study completion Aug 12, 2025
Sponsor
- Lead sponsor
- Apollo Therapeutics LtdIndustry
- Sponsor type
- Industry
- First posted
- May 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety of camoteskimab in adults with moderate to severe AD.
Conditions
- Atopic Dermatitis
- Atopic
- Dermatitis
- Dermatologic Disease
- Eczema
- Eczema Atopic Dermatitis
- Eczema, Atopic
Interventions
CamoteskimabDrug
Drug Product
PlaceboDrug
Inactive substance
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change from baseline in Eczema Area and Severity Index (EASI) between camoteskimab and placebo at Week 12Time frame: 12 weeks
Locations
35 sites in 2 countries. Site status is shown where the registry gives one.
Medical Dermatology Specialists, PC/US Dermatology Partners
Phoenix, Arizona
California Dermatology & Clinical Research Institute
Encinitas, California
First OC Dermatology Research, Inc.
Fountain Valley, California
Center for Dermatology Clinical Research, Inc.
Fremont, California
California Allergy and Asthma Medical Group
Los Angeles, California
University of California Los Angeles Dermatology
Los Angeles, California
Amicis Research Center (Northridge)
Northridge, California
Cura Clinical Research
Oxnard, California
VASDHS - Veterans Affairs San Diego Medical Center
San Diego, California
Clinical Sciences Institute
Santa Monica, California
Renaissance Research and Medical Group
Cape Coral, Florida
D&H National Research Centers, Inc.
Miami, Florida
Avita Clinical Research - Dermatology
Tampa, Florida
Sneeze, Wheeze & Itch Associates, LLC
Normal, Illinois
Dawes Fretzin Clinical Research
Indianapolis, Indiana
Skin Sciences, PLLC
Louisville, Kentucky
Owensboro Dermatology Associates
Owensboro, Kentucky
Revival Research Institute
Troy, Michigan
Somerset Skin Centre
Troy, Michigan
Michigan Dermatology Institute
Waterford, Michigan
Advanced Dermatology and Skin Cancer Center - Saint Joseph
Saint Joseph, Missouri
Skin Specialists PC
Omaha, Nebraska
M3 Wake Research, Inc.
Raleigh, North Carolina
ObjectiveHealth-The Skin Surgery Center for Clinical Research
Winston-Salem, North Carolina
Central Sooner Research
Oklahoma City, Oklahoma
Unity Clinical Research - Dermatology
Oklahoma City, Oklahoma
Paddington Testing Co. Inc
Philadelphia, Pennsylvania
Rodgers Dermatology
Frisco, Texas
Center for Clinical Studies
Houston, Texas
Clinical Trial Network
Houston, Texas
Youthful Image
Edmonton, Alberta, Canada
Rejuvenation Dermatology Clinic Edmonton South
Edmonton, Alberta, Canada
Kingsway Clinical Research
Etobicoke, Ontario, Canada
Clinique Medicale Saint-Louis
Québec, Quebec, Canada
Clinique Dermatologique de Sherbrooke
Sherbrooke, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.